WUXI PHARMATECH CAYMAN INC - SPONS ADR SHS (WX)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / SPONS ADR SHS
Total 13F shares
58,830,919
Share change
-3,485,613
Total reported value
$2,480,794,232
Put/Call ratio
380%
Price per share
$42.26
Number of holders
152
Value change
-$134,336,872
Number of buys
76
Number of sells
93

Institutional Holders of WUXI PHARMATECH CAYMAN INC - SPONS ADR SHS (WX) as of Q2 2015

As of 30 Jun 2015, WUXI PHARMATECH CAYMAN INC - SPONS ADR SHS (WX) was held by 152 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,830,919 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, SCHRODER INVESTMENT MANAGEMENT GROUP, FIL Ltd, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Investec Asset Management LTD, COMMONWEALTH BANK OF AUSTRALIA, OPPENHEIMER FUNDS INC, FMR LLC, COMGEST GLOBAL INVESTORS S.A.S., and Apex Capital Management. This page lists 152 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.